Inflammatory Biomarkers as Additional Tool to Neuroimaging in the Diagnosis and Management of Patients With Ischemic Stroke
N/A
18 Years
85 Years
18 Years
85 Years
Not Enrolling
Both
Cerebrovascular Accident
Both
Cerebrovascular Accident
Trial Information
Inflammatory Biomarkers as Additional Tool to Neuroimaging in the Diagnosis and Management of Patients With Ischemic Stroke
Inclusion Criteria:
1. Ability to provide written informed consent and to be compliant with the schedule of
protocol assessments
2. Diagnosis of acute clinical stroke
3. Ages 18 and above inclusive
4. Both genders eligible for the study
Exclusion Criteria:
1. Intracerebral hemorrhage according to Computed Tomography (CT)
2. Clinical signs of infection on admission
3. Patients with chronic inflammatory disease
4. Hematologic disorders (anemia)
5. Malignant tumor
6. Renal or hepatic failure
7. Treatment with anti-inflammatory or corticosteroids drugs within a month before
stroke
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Relationship between inflammatory biomarkers and CVA patients
Outcome Description:
To assess the levels over the time of selected inflammatory biomarkers, to determine the relationship between them after acute ischemic stroke and to evaluate their correlation with patients characteristics
Outcome Time Frame:
Follow-up 1 year
Safety Issue:
No
Principal Investigator
Saad Abu Saleh, MD
Investigator Role:
Study Director
Investigator Affiliation:
Ziv Medical Center
Authority:
Israel: Ministry of Health
Study ID:
0064-12-ZIV
NCT ID:
NCT01787877
Start Date:
February 2013
Completion Date:
Related Keywords:
- Cerebrovascular Accident
- Cerebrovascular Accident, Inflammatory biomarkers
- Cerebral Infarction
- Stroke
Name | Location |
|---|
